Henan Lingrui Pharmaceutical Statistics

Total Valuation

Henan Lingrui Pharmaceutical has a market cap or net worth of CNY 12.89 billion. The enterprise value is 12.07 billion.

Market Cap	12.89B
Enterprise Value	12.07B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jun 20, 2024

Share Statistics

Henan Lingrui Pharmaceutical has 563.16 million shares outstanding. The number of shares has increased by 0.01% in one year.

Shares Outstanding	563.16M
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	1.40%
Owned by Institutions (%)	24.92%
Float	433.43M

Valuation Ratios

The trailing PE ratio is 19.48 and the forward PE ratio is 18.66. Henan Lingrui Pharmaceutical's PEG ratio is 0.98.

PE Ratio	19.48
Forward PE	18.66
PS Ratio	3.66
PB Ratio	4.77
P/FCF Ratio	18.90
PEG Ratio	0.98

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.78, with an EV/FCF ratio of 17.71.

EV / Earnings	18.17
EV / Sales	3.43
EV / EBITDA	15.78
EV / EBIT	17.50
EV / FCF	17.71

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 3.10.

Current Ratio	1.08
Quick Ratio	0.84
Debt / Equity	3.10
Debt / EBITDA	0.11
Debt / FCF	0.12
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 25.25% and return on invested capital (ROIC) is 15.73%.

Return on Equity (ROE)	25.25%
Return on Assets (ROA)	9.51%
Return on Capital (ROIC)	15.73%
Revenue Per Employee	1.39M
Profits Per Employee	262,514
Employee Count	2,530
Asset Turnover	0.78
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.83% in the last 52 weeks. The beta is 0.32, so Henan Lingrui Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+45.83%
50-Day Moving Average	23.24
200-Day Moving Average	21.24
Relative Strength Index (RSI)	43.18
Average Volume (20 Days)	6,876,862

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Henan Lingrui Pharmaceutical had revenue of CNY 3.52 billion and earned 664.16 million in profits. Earnings per share was 1.17.

Revenue	3.52B
Gross Profit	2.59B
Operating Income	689.50M
Pretax Income	767.69M
Net Income	664.16M
EBITDA	762.88M
EBIT	689.50M
Earnings Per Share (EPS)	1.17

Full Income Statement

Balance Sheet

The company has 907.71 million in cash and 84.01 million in debt, giving a net cash position of 823.70 million or 1.46 per share.

Cash & Cash Equivalents	907.71M
Total Debt	84.01M
Net Cash	823.70M
Net Cash Per Share	1.46
Equity (Book Value)	2.71B
Book Value Per Share	4.80
Working Capital	160.49M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 710.86 million and capital expenditures -29.20 million, giving a free cash flow of 681.65 million.

Operating Cash Flow	710.86M
Capital Expenditures	-29.20M
Free Cash Flow	681.65M
FCF Per Share	1.21

Full Cash Flow Statement

Margins

Gross margin is 73.68%, with operating and profit margins of 19.61% and 18.89%.

Gross Margin	73.68%
Operating Margin	19.61%
Pretax Margin	21.83%
Profit Margin	18.89%
EBITDA Margin	21.69%
EBIT Margin	19.61%
FCF Margin	19.38%

Dividends & Yields

This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.50%.

Dividend Per Share	0.80
Dividend Yield	3.50%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	4
Payout Ratio	68.96%
Buyback Yield	-0.01%
Shareholder Yield	3.49%
Earnings Yield	5.13%
FCF Yield	5.29%

Dividend Details

Stock Splits

The last stock split was on July 2, 2014. It was a forward split with a ratio of 1.5.

Last Split Date	Jul 2, 2014
Split Type	Forward
Split Ratio	1.5